Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer

por Wall, Jaclyn A., Arend, Rebecca C.
Publicado 2020

Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies

por Dholakia, Jhalak, Scalise, Carly, Arend, Rebecca C.
Publicado 2021

Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer

por Roane, Brandon M., Arend, Rebecca C., Birrer, Michael J.
Publicado 2019

Checkpoint inhibitors in ovarian cancer: A review of preclinical data

por Doo, David W., Norian, Lyse A., Arend, Rebecca C.
Publicado 2019

Revisiting entinostat as an immune-potentiating adjuvant

por McCaw, Tyler R., Randall, Troy D., Arend, Rebecca C.
Publicado 2018

Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review

por Smith, Haller J., Straughn, J. Michael, Buchsbaum, Donald J., Arend, Rebecca C.
Publicado 2017

Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial

por Cohen, Caroline W., Fontaine, Kevin R., Arend, Rebecca C., Soleymani, Taraneh, Gower, Barbara A.
Publicado 2018

A Review of the Role of Wnt in Cancer Immunomodulation

por Goldsberry, Whitney N., Londoño, Angelina, Randall, Troy D., Norian, Lyse A., Arend, Rebecca C.
Publicado 2019

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease

por Arend, Rebecca C., Jackson-Fisher, Amy, Jacobs, Ira A., Chou, Jeffrey, Monk, Bradley J.
Publicado 2021

TGFβ signaling networks in ovarian cancer progression and plasticity

por Kumari, Asha, Shonibare, Zainab, Monavarian, Mehri, Arend, Rebecca C., Lee, Nam Y., Inman, Gareth J., Mythreye, Karthikeyan
Publicado 2021

Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data

por Arend, Rebecca C., O’Malley, David M., Banerjee, Susana, McLaurin, Kimmie, Davidson, Richard, Long, Gráinne H.
Publicado 2021

Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology

por Martinez, Alba, Buckley, Molly S, Scalise, Carly B, Wang, Dezhi, Katre, Ashwini A, Birrer, Michael J, Berry, Joel L, Arend, Rebecca C
Publicado 2021

Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer

por Arend, Rebecca C., Scalise, Carly B., Dholakia, Jhalak, Kamal, Maahum Z., Thigpen, Haley B., Crossman, David, Huh, Warner K., Leath, Charles A.
Publicado 2021

Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer

por McCaw, Tyler R., Goel, Nidhi, Brooke, Dewey J., Katre, Ashwini A., Londoño, Angelina I., Smith, Haller J., Randall, Troy D., Arend, Rebecca C.
Publicado 2020

Insulin‐like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma

por Van Arsdale, Anne R., Arend, Rebecca C., Cossio, Maria J., Erickson, Britt K., Wang, Yanhua, Doo, David W., Leath, Charles A., Goldberg, Gary L., Huang, Gloria S.
Publicado 2018

PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance

por Tabury, Kevin, Monavarian, Mehri, Listik, Eduardo, Shelton, Abigail K, Choi, Alex Seok, Quintens, Roel, Arend, Rebecca C, Hempel, Nadine, Miller, C Ryan, Györrfy, Balázs, Mythreye, Karthikeyan
Publicado 2022

Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth

por Turner, Taylor B, Meza-Perez, Selene, Londoño, Angelina, Katre, Ashwini, Peabody, Jacelyn E., Smith, Haller J., Forero, Andres, Norian, Lyse A, Straughn, J. Michael, Buchsbaum, Donald J., Rand all, Troy D., Arend, Rebecca C.
Publicado 2017

Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment

por Goldsberry, Whitney N., Meza-Perez, Selene, Londoño, Angelina I., Katre, Ashwini A., Mott, Bryan T., Roane, Brandon M., Goel, Nidhi, Wall, Jaclyn A., Cooper, Sara J., Norian, Lyse A., Randall, Troy D., Birrer, Michael J., Arend, Rebecca C.
Publicado 2020

Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector

por Peng, Shiwen, Tu, Hsin-Fang, Cheng, Michelle, Hu, Ming-Hung, Tsai, Hua-Ling, Tsai, Ya-Chea, Koenig, Chelsea, Brayton, Cory, Wang, Hao, Chang, Yung-Nien, Arend, Rebecca C., Levinson, Kimberly, Roden, Richard B. S., Wu, T. C., Hung, Chien-Fu
Publicado 2023

Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer

por Arend, Rebecca C., Londoño-Joshi, Angelina I., Gangrade, Abhishek, Katre, Ashwini A., Kurpad, Chandrika, Li, Yonghe, Samant, Rajeev S., Li, Pui-Kai, Landen, Charles N., Yang, Eddy S., Hidalgo, Bertha, Alvarez, Ronald D., Michael Straughn, John, Forero, Andres, Buchsbaum, Donald J.
Publicado 2016